nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—Depression—Galantamine—Alzheimer's disease	0.00317	0.00355	CcSEcCtD
Atenolol—Affect lability—Donepezil—Alzheimer's disease	0.00315	0.00352	CcSEcCtD
Atenolol—Libido decreased—Memantine—Alzheimer's disease	0.00313	0.0035	CcSEcCtD
Atenolol—Renal failure—Galantamine—Alzheimer's disease	0.00313	0.0035	CcSEcCtD
Atenolol—Psychotic disorder—Donepezil—Alzheimer's disease	0.00312	0.00349	CcSEcCtD
Atenolol—Hot flush—Memantine—Alzheimer's disease	0.0031	0.00347	CcSEcCtD
Atenolol—Amnesia—Memantine—Alzheimer's disease	0.00309	0.00346	CcSEcCtD
Atenolol—Menopausal symptoms—Memantine—Alzheimer's disease	0.00308	0.00344	CcSEcCtD
Atenolol—Atrial fibrillation—Memantine—Alzheimer's disease	0.00306	0.00343	CcSEcCtD
Atenolol—Libido decreased—Rivastigmine—Alzheimer's disease	0.00306	0.00343	CcSEcCtD
Atenolol—Hot flush—Rivastigmine—Alzheimer's disease	0.00304	0.0034	CcSEcCtD
Atenolol—Mood swings—Donepezil—Alzheimer's disease	0.00303	0.00339	CcSEcCtD
Atenolol—Amnesia—Rivastigmine—Alzheimer's disease	0.00302	0.00338	CcSEcCtD
Atenolol—Purpura—Memantine—Alzheimer's disease	0.00301	0.00337	CcSEcCtD
Atenolol—Menopausal symptoms—Rivastigmine—Alzheimer's disease	0.00301	0.00337	CcSEcCtD
Atenolol—Ataxia—Donepezil—Alzheimer's disease	0.00301	0.00336	CcSEcCtD
Atenolol—Epistaxis—Galantamine—Alzheimer's disease	0.003	0.00335	CcSEcCtD
Atenolol—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.003	0.00335	CcSEcCtD
Atenolol—Cardiac failure—Memantine—Alzheimer's disease	0.00298	0.00333	CcSEcCtD
Atenolol—Lethargy—Memantine—Alzheimer's disease	0.00296	0.00331	CcSEcCtD
Atenolol—Purpura—Rivastigmine—Alzheimer's disease	0.00295	0.0033	CcSEcCtD
Atenolol—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.00292	0.00327	CcSEcCtD
Atenolol—Cardiac failure—Rivastigmine—Alzheimer's disease	0.00291	0.00326	CcSEcCtD
Atenolol—Bradycardia—Galantamine—Alzheimer's disease	0.00291	0.00325	CcSEcCtD
Atenolol—Pain in extremity—Memantine—Alzheimer's disease	0.0029	0.00325	CcSEcCtD
Atenolol—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.00288	0.00322	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.00288	0.00322	CcSEcCtD
Atenolol—Affect lability—Memantine—Alzheimer's disease	0.00286	0.0032	CcSEcCtD
Atenolol—Pain in extremity—Rivastigmine—Alzheimer's disease	0.00284	0.00318	CcSEcCtD
Atenolol—Hallucination—Galantamine—Alzheimer's disease	0.00284	0.00318	CcSEcCtD
Atenolol—Psychotic disorder—Memantine—Alzheimer's disease	0.00284	0.00317	CcSEcCtD
Atenolol—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.00282	0.00315	CcSEcCtD
Atenolol—Affect lability—Rivastigmine—Alzheimer's disease	0.0028	0.00313	CcSEcCtD
Atenolol—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.00277	0.0031	CcSEcCtD
Atenolol—Cardiac arrest—Memantine—Alzheimer's disease	0.00276	0.00309	CcSEcCtD
Atenolol—Visual impairment—Galantamine—Alzheimer's disease	0.00275	0.00308	CcSEcCtD
Atenolol—Mood swings—Memantine—Alzheimer's disease	0.00275	0.00308	CcSEcCtD
Atenolol—Ataxia—Memantine—Alzheimer's disease	0.00273	0.00305	CcSEcCtD
Atenolol—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.0027	0.00302	CcSEcCtD
Atenolol—Mood swings—Rivastigmine—Alzheimer's disease	0.00269	0.00301	CcSEcCtD
Atenolol—Ataxia—Rivastigmine—Alzheimer's disease	0.00267	0.00299	CcSEcCtD
Atenolol—Tinnitus—Galantamine—Alzheimer's disease	0.00266	0.00298	CcSEcCtD
Atenolol—Orthostatic hypotension—Memantine—Alzheimer's disease	0.00265	0.00297	CcSEcCtD
Atenolol—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00265	0.00296	CcSEcCtD
Atenolol—Flushing—Galantamine—Alzheimer's disease	0.00265	0.00296	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.00261	0.00292	CcSEcCtD
Atenolol—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.00259	0.0029	CcSEcCtD
Atenolol—Chlorphenesin—BCHE—Alzheimer's disease	0.00256	0.143	CrCbGaD
Atenolol—Arrhythmia—Galantamine—Alzheimer's disease	0.00255	0.00285	CcSEcCtD
Atenolol—Bronchospasm—Memantine—Alzheimer's disease	0.00247	0.00276	CcSEcCtD
Atenolol—Depression—Donepezil—Alzheimer's disease	0.00246	0.00275	CcSEcCtD
Atenolol—Tension—Galantamine—Alzheimer's disease	0.00244	0.00273	CcSEcCtD
Atenolol—Renal failure—Donepezil—Alzheimer's disease	0.00242	0.00271	CcSEcCtD
Atenolol—Myocardial infarction—Donepezil—Alzheimer's disease	0.00242	0.0027	CcSEcCtD
Atenolol—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00241	0.0027	CcSEcCtD
Atenolol—Nervousness—Galantamine—Alzheimer's disease	0.00241	0.0027	CcSEcCtD
Atenolol—Sweating—Donepezil—Alzheimer's disease	0.00236	0.00264	CcSEcCtD
Atenolol—Vision blurred—Galantamine—Alzheimer's disease	0.00234	0.00262	CcSEcCtD
Atenolol—Epistaxis—Donepezil—Alzheimer's disease	0.00232	0.0026	CcSEcCtD
Atenolol—Erectile dysfunction—Memantine—Alzheimer's disease	0.00231	0.00259	CcSEcCtD
Atenolol—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00231	0.00258	CcSEcCtD
Atenolol—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00226	0.00253	CcSEcCtD
Atenolol—Ibuprofen—BCL2—Alzheimer's disease	0.00225	0.126	CrCbGaD
Atenolol—Bradycardia—Donepezil—Alzheimer's disease	0.00225	0.00252	CcSEcCtD
Atenolol—Malaise—Galantamine—Alzheimer's disease	0.00224	0.00251	CcSEcCtD
Atenolol—Vertigo—Galantamine—Alzheimer's disease	0.00223	0.0025	CcSEcCtD
Atenolol—Depression—Memantine—Alzheimer's disease	0.00223	0.0025	CcSEcCtD
Atenolol—Syncope—Galantamine—Alzheimer's disease	0.00223	0.00249	CcSEcCtD
Atenolol—Hallucination—Donepezil—Alzheimer's disease	0.0022	0.00246	CcSEcCtD
Atenolol—Renal failure—Memantine—Alzheimer's disease	0.0022	0.00246	CcSEcCtD
Atenolol—Palpitations—Galantamine—Alzheimer's disease	0.0022	0.00246	CcSEcCtD
Atenolol—Myocardial infarction—Memantine—Alzheimer's disease	0.00219	0.00245	CcSEcCtD
Atenolol—Drowsiness—Rivastigmine—Alzheimer's disease	0.00219	0.00245	CcSEcCtD
Atenolol—Loss of consciousness—Galantamine—Alzheimer's disease	0.00218	0.00244	CcSEcCtD
Atenolol—Depression—Rivastigmine—Alzheimer's disease	0.00218	0.00244	CcSEcCtD
Atenolol—Cough—Galantamine—Alzheimer's disease	0.00217	0.00243	CcSEcCtD
Atenolol—Renal failure—Rivastigmine—Alzheimer's disease	0.00215	0.00241	CcSEcCtD
Atenolol—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00215	0.0024	CcSEcCtD
Atenolol—Visual impairment—Donepezil—Alzheimer's disease	0.00213	0.00238	CcSEcCtD
Atenolol—Chest pain—Galantamine—Alzheimer's disease	0.00212	0.00237	CcSEcCtD
Atenolol—Epistaxis—Memantine—Alzheimer's disease	0.00211	0.00236	CcSEcCtD
Atenolol—Anxiety—Galantamine—Alzheimer's disease	0.00211	0.00236	CcSEcCtD
Atenolol—Sweating—Rivastigmine—Alzheimer's disease	0.0021	0.00235	CcSEcCtD
Atenolol—Discomfort—Galantamine—Alzheimer's disease	0.00209	0.00234	CcSEcCtD
Atenolol—Agranulocytosis—Memantine—Alzheimer's disease	0.00209	0.00234	CcSEcCtD
Atenolol—Dry mouth—Galantamine—Alzheimer's disease	0.00207	0.00231	CcSEcCtD
Atenolol—Epistaxis—Rivastigmine—Alzheimer's disease	0.00206	0.00231	CcSEcCtD
Atenolol—Tinnitus—Donepezil—Alzheimer's disease	0.00206	0.00231	CcSEcCtD
Atenolol—Confusional state—Galantamine—Alzheimer's disease	0.00204	0.00229	CcSEcCtD
Atenolol—Bradycardia—Memantine—Alzheimer's disease	0.00204	0.00229	CcSEcCtD
Atenolol—Bradycardia—Rivastigmine—Alzheimer's disease	0.002	0.00224	CcSEcCtD
Atenolol—Hallucination—Memantine—Alzheimer's disease	0.002	0.00224	CcSEcCtD
Atenolol—Shock—Galantamine—Alzheimer's disease	0.002	0.00223	CcSEcCtD
Atenolol—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00199	0.00222	CcSEcCtD
Atenolol—Tachycardia—Galantamine—Alzheimer's disease	0.00198	0.00221	CcSEcCtD
Atenolol—Arrhythmia—Donepezil—Alzheimer's disease	0.00198	0.00221	CcSEcCtD
Atenolol—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00196	0.00219	CcSEcCtD
Atenolol—Hallucination—Rivastigmine—Alzheimer's disease	0.00196	0.00219	CcSEcCtD
Atenolol—Alopecia—Donepezil—Alzheimer's disease	0.00195	0.00219	CcSEcCtD
Atenolol—Visual impairment—Memantine—Alzheimer's disease	0.00194	0.00217	CcSEcCtD
Atenolol—Anorexia—Galantamine—Alzheimer's disease	0.00193	0.00216	CcSEcCtD
Atenolol—Hypotension—Galantamine—Alzheimer's disease	0.0019	0.00212	CcSEcCtD
Atenolol—Visual impairment—Rivastigmine—Alzheimer's disease	0.00189	0.00212	CcSEcCtD
Atenolol—Tension—Donepezil—Alzheimer's disease	0.00189	0.00211	CcSEcCtD
Atenolol—Tinnitus—Memantine—Alzheimer's disease	0.00187	0.00209	CcSEcCtD
Atenolol—Nervousness—Donepezil—Alzheimer's disease	0.00187	0.00209	CcSEcCtD
Atenolol—Flushing—Memantine—Alzheimer's disease	0.00186	0.00209	CcSEcCtD
Atenolol—Insomnia—Galantamine—Alzheimer's disease	0.00183	0.00205	CcSEcCtD
Atenolol—Tinnitus—Rivastigmine—Alzheimer's disease	0.00183	0.00205	CcSEcCtD
Atenolol—Flushing—Rivastigmine—Alzheimer's disease	0.00182	0.00204	CcSEcCtD
Atenolol—Paraesthesia—Galantamine—Alzheimer's disease	0.00182	0.00204	CcSEcCtD
Atenolol—Vision blurred—Donepezil—Alzheimer's disease	0.00182	0.00203	CcSEcCtD
Atenolol—Somnolence—Galantamine—Alzheimer's disease	0.0018	0.00202	CcSEcCtD
Atenolol—Arrhythmia—Memantine—Alzheimer's disease	0.00179	0.00201	CcSEcCtD
Atenolol—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00179	0.002	CcSEcCtD
Atenolol—Dyspepsia—Galantamine—Alzheimer's disease	0.00179	0.002	CcSEcCtD
Atenolol—Alopecia—Memantine—Alzheimer's disease	0.00178	0.00199	CcSEcCtD
Atenolol—Decreased appetite—Galantamine—Alzheimer's disease	0.00176	0.00197	CcSEcCtD
Atenolol—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00176	0.00196	CcSEcCtD
Atenolol—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00175	0.00196	CcSEcCtD
Atenolol—Fatigue—Galantamine—Alzheimer's disease	0.00175	0.00196	CcSEcCtD
Atenolol—Malaise—Donepezil—Alzheimer's disease	0.00174	0.00194	CcSEcCtD
Atenolol—Alopecia—Rivastigmine—Alzheimer's disease	0.00174	0.00194	CcSEcCtD
Atenolol—Constipation—Galantamine—Alzheimer's disease	0.00173	0.00194	CcSEcCtD
Atenolol—Vertigo—Donepezil—Alzheimer's disease	0.00173	0.00194	CcSEcCtD
Atenolol—Syncope—Donepezil—Alzheimer's disease	0.00173	0.00193	CcSEcCtD
Atenolol—Tension—Memantine—Alzheimer's disease	0.00172	0.00192	CcSEcCtD
Atenolol—Nervousness—Memantine—Alzheimer's disease	0.0017	0.0019	CcSEcCtD
Atenolol—Loss of consciousness—Donepezil—Alzheimer's disease	0.00169	0.00189	CcSEcCtD
Atenolol—Cough—Donepezil—Alzheimer's disease	0.00168	0.00188	CcSEcCtD
Atenolol—Tension—Rivastigmine—Alzheimer's disease	0.00168	0.00188	CcSEcCtD
Atenolol—Feeling abnormal—Galantamine—Alzheimer's disease	0.00167	0.00187	CcSEcCtD
Atenolol—Nervousness—Rivastigmine—Alzheimer's disease	0.00166	0.00186	CcSEcCtD
Atenolol—Vision blurred—Memantine—Alzheimer's disease	0.00165	0.00184	CcSEcCtD
Atenolol—Chest pain—Donepezil—Alzheimer's disease	0.00164	0.00183	CcSEcCtD
Atenolol—Anxiety—Donepezil—Alzheimer's disease	0.00163	0.00183	CcSEcCtD
Atenolol—Ill-defined disorder—Memantine—Alzheimer's disease	0.00162	0.00181	CcSEcCtD
Atenolol—Discomfort—Donepezil—Alzheimer's disease	0.00162	0.00181	CcSEcCtD
Atenolol—Vision blurred—Rivastigmine—Alzheimer's disease	0.00161	0.0018	CcSEcCtD
Atenolol—Dry mouth—Donepezil—Alzheimer's disease	0.0016	0.00179	CcSEcCtD
Atenolol—Body temperature increased—Galantamine—Alzheimer's disease	0.0016	0.00179	CcSEcCtD
Atenolol—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00159	0.00178	CcSEcCtD
Atenolol—Confusional state—Donepezil—Alzheimer's disease	0.00158	0.00177	CcSEcCtD
Atenolol—Malaise—Memantine—Alzheimer's disease	0.00158	0.00176	CcSEcCtD
Atenolol—Oedema—Donepezil—Alzheimer's disease	0.00157	0.00176	CcSEcCtD
Atenolol—Vertigo—Memantine—Alzheimer's disease	0.00157	0.00176	CcSEcCtD
Atenolol—Syncope—Memantine—Alzheimer's disease	0.00157	0.00175	CcSEcCtD
Atenolol—Shock—Donepezil—Alzheimer's disease	0.00155	0.00173	CcSEcCtD
Atenolol—Palpitations—Memantine—Alzheimer's disease	0.00155	0.00173	CcSEcCtD
Atenolol—Malaise—Rivastigmine—Alzheimer's disease	0.00154	0.00173	CcSEcCtD
Atenolol—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00154	0.00172	CcSEcCtD
Atenolol—Vertigo—Rivastigmine—Alzheimer's disease	0.00154	0.00172	CcSEcCtD
Atenolol—Loss of consciousness—Memantine—Alzheimer's disease	0.00154	0.00172	CcSEcCtD
Atenolol—Syncope—Rivastigmine—Alzheimer's disease	0.00153	0.00172	CcSEcCtD
Atenolol—Cough—Memantine—Alzheimer's disease	0.00153	0.00171	CcSEcCtD
Atenolol—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00152	0.0017	CcSEcCtD
Atenolol—Palpitations—Rivastigmine—Alzheimer's disease	0.00151	0.00169	CcSEcCtD
Atenolol—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.0015	0.00168	CcSEcCtD
Atenolol—Anorexia—Donepezil—Alzheimer's disease	0.0015	0.00168	CcSEcCtD
Atenolol—Cough—Rivastigmine—Alzheimer's disease	0.00149	0.00167	CcSEcCtD
Atenolol—Chest pain—Memantine—Alzheimer's disease	0.00149	0.00167	CcSEcCtD
Atenolol—Anxiety—Memantine—Alzheimer's disease	0.00148	0.00166	CcSEcCtD
Atenolol—Discomfort—Memantine—Alzheimer's disease	0.00147	0.00165	CcSEcCtD
Atenolol—Hypotension—Donepezil—Alzheimer's disease	0.00147	0.00164	CcSEcCtD
Atenolol—Chest pain—Rivastigmine—Alzheimer's disease	0.00146	0.00163	CcSEcCtD
Atenolol—Dry mouth—Memantine—Alzheimer's disease	0.00146	0.00163	CcSEcCtD
Atenolol—Asthenia—Galantamine—Alzheimer's disease	0.00146	0.00163	CcSEcCtD
Atenolol—Anxiety—Rivastigmine—Alzheimer's disease	0.00145	0.00162	CcSEcCtD
Atenolol—Confusional state—Memantine—Alzheimer's disease	0.00144	0.00161	CcSEcCtD
Atenolol—Discomfort—Rivastigmine—Alzheimer's disease	0.00144	0.00161	CcSEcCtD
Atenolol—Oedema—Memantine—Alzheimer's disease	0.00143	0.0016	CcSEcCtD
Atenolol—Dry mouth—Rivastigmine—Alzheimer's disease	0.00142	0.00159	CcSEcCtD
Atenolol—Insomnia—Donepezil—Alzheimer's disease	0.00142	0.00159	CcSEcCtD
Atenolol—Betaxolol—CYP2D6—Alzheimer's disease	0.00142	0.0792	CrCbGaD
Atenolol—Paraesthesia—Donepezil—Alzheimer's disease	0.00141	0.00158	CcSEcCtD
Atenolol—Confusional state—Rivastigmine—Alzheimer's disease	0.00141	0.00157	CcSEcCtD
Atenolol—Shock—Memantine—Alzheimer's disease	0.0014	0.00157	CcSEcCtD
Atenolol—Dyspnoea—Donepezil—Alzheimer's disease	0.0014	0.00157	CcSEcCtD
Atenolol—Somnolence—Donepezil—Alzheimer's disease	0.0014	0.00156	CcSEcCtD
Atenolol—Thrombocytopenia—Memantine—Alzheimer's disease	0.0014	0.00156	CcSEcCtD
Atenolol—Oedema—Rivastigmine—Alzheimer's disease	0.0014	0.00156	CcSEcCtD
Atenolol—Tachycardia—Memantine—Alzheimer's disease	0.00139	0.00156	CcSEcCtD
Atenolol—Diarrhoea—Galantamine—Alzheimer's disease	0.00139	0.00155	CcSEcCtD
Atenolol—Dyspepsia—Donepezil—Alzheimer's disease	0.00138	0.00155	CcSEcCtD
Atenolol—Hyperhidrosis—Memantine—Alzheimer's disease	0.00138	0.00154	CcSEcCtD
Atenolol—Shock—Rivastigmine—Alzheimer's disease	0.00137	0.00154	CcSEcCtD
Atenolol—Bisoprolol—CYP2D6—Alzheimer's disease	0.00137	0.0765	CrCbGaD
Atenolol—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00137	0.00153	CcSEcCtD
Atenolol—Decreased appetite—Donepezil—Alzheimer's disease	0.00137	0.00153	CcSEcCtD
Atenolol—Tachycardia—Rivastigmine—Alzheimer's disease	0.00136	0.00152	CcSEcCtD
Atenolol—Anorexia—Memantine—Alzheimer's disease	0.00136	0.00152	CcSEcCtD
Atenolol—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00136	0.00152	CcSEcCtD
Atenolol—Fatigue—Donepezil—Alzheimer's disease	0.00136	0.00152	CcSEcCtD
Atenolol—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00135	0.00151	CcSEcCtD
Atenolol—Constipation—Donepezil—Alzheimer's disease	0.00134	0.0015	CcSEcCtD
Atenolol—Pain—Donepezil—Alzheimer's disease	0.00134	0.0015	CcSEcCtD
Atenolol—Dizziness—Galantamine—Alzheimer's disease	0.00134	0.0015	CcSEcCtD
Atenolol—Hypotension—Memantine—Alzheimer's disease	0.00133	0.00149	CcSEcCtD
Atenolol—Anorexia—Rivastigmine—Alzheimer's disease	0.00133	0.00149	CcSEcCtD
Atenolol—Hypotension—Rivastigmine—Alzheimer's disease	0.0013	0.00146	CcSEcCtD
Atenolol—Acebutolol—CYP2D6—Alzheimer's disease	0.0013	0.0725	CrCbGaD
Atenolol—Feeling abnormal—Donepezil—Alzheimer's disease	0.0013	0.00145	CcSEcCtD
Atenolol—Insomnia—Memantine—Alzheimer's disease	0.00129	0.00144	CcSEcCtD
Atenolol—Oxprenolol—CYP2D6—Alzheimer's disease	0.00129	0.0719	CrCbGaD
Atenolol—Paraesthesia—Memantine—Alzheimer's disease	0.00128	0.00143	CcSEcCtD
Atenolol—Rash—Galantamine—Alzheimer's disease	0.00128	0.00143	CcSEcCtD
Atenolol—Dermatitis—Galantamine—Alzheimer's disease	0.00128	0.00143	CcSEcCtD
Atenolol—Dyspnoea—Memantine—Alzheimer's disease	0.00127	0.00142	CcSEcCtD
Atenolol—Headache—Galantamine—Alzheimer's disease	0.00127	0.00142	CcSEcCtD
Atenolol—Somnolence—Memantine—Alzheimer's disease	0.00127	0.00142	CcSEcCtD
Atenolol—Insomnia—Rivastigmine—Alzheimer's disease	0.00126	0.00141	CcSEcCtD
Atenolol—Dyspepsia—Memantine—Alzheimer's disease	0.00126	0.00141	CcSEcCtD
Atenolol—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00125	0.0014	CcSEcCtD
Atenolol—Ibuprofen—PPARG—Alzheimer's disease	0.00125	0.0697	CrCbGaD
Atenolol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00124	0.00139	CcSEcCtD
Atenolol—Body temperature increased—Donepezil—Alzheimer's disease	0.00124	0.00139	CcSEcCtD
Atenolol—Somnolence—Rivastigmine—Alzheimer's disease	0.00124	0.00139	CcSEcCtD
Atenolol—Decreased appetite—Memantine—Alzheimer's disease	0.00124	0.00139	CcSEcCtD
Atenolol—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00123	0.00138	CcSEcCtD
Atenolol—Fatigue—Memantine—Alzheimer's disease	0.00123	0.00138	CcSEcCtD
Atenolol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00123	0.00137	CcSEcCtD
Atenolol—Constipation—Memantine—Alzheimer's disease	0.00122	0.00136	CcSEcCtD
Atenolol—Pain—Memantine—Alzheimer's disease	0.00122	0.00136	CcSEcCtD
Atenolol—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00121	0.00136	CcSEcCtD
Atenolol—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00121	0.00135	CcSEcCtD
Atenolol—Nausea—Galantamine—Alzheimer's disease	0.0012	0.00135	CcSEcCtD
Atenolol—Fatigue—Rivastigmine—Alzheimer's disease	0.0012	0.00135	CcSEcCtD
Atenolol—Constipation—Rivastigmine—Alzheimer's disease	0.00119	0.00134	CcSEcCtD
Atenolol—Pain—Rivastigmine—Alzheimer's disease	0.00119	0.00134	CcSEcCtD
Atenolol—Chlorphenesin—PTGS2—Alzheimer's disease	0.00118	0.0659	CrCbGaD
Atenolol—Alprenolol—CYP2D6—Alzheimer's disease	0.00118	0.0658	CrCbGaD
Atenolol—Feeling abnormal—Memantine—Alzheimer's disease	0.00118	0.00132	CcSEcCtD
Atenolol—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00115	0.00129	CcSEcCtD
Atenolol—Body temperature increased—Memantine—Alzheimer's disease	0.00113	0.00126	CcSEcCtD
Atenolol—Asthenia—Donepezil—Alzheimer's disease	0.00113	0.00126	CcSEcCtD
Atenolol—Pruritus—Donepezil—Alzheimer's disease	0.00111	0.00124	CcSEcCtD
Atenolol—Body temperature increased—Rivastigmine—Alzheimer's disease	0.0011	0.00123	CcSEcCtD
Atenolol—Metoprolol—CYP2D6—Alzheimer's disease	0.0011	0.0612	CrCbGaD
Atenolol—Diarrhoea—Donepezil—Alzheimer's disease	0.00108	0.0012	CcSEcCtD
Atenolol—Dizziness—Donepezil—Alzheimer's disease	0.00104	0.00116	CcSEcCtD
Atenolol—Asthenia—Memantine—Alzheimer's disease	0.00102	0.00115	CcSEcCtD
Atenolol—Pindolol—CYP2D6—Alzheimer's disease	0.00101	0.0566	CrCbGaD
Atenolol—Pruritus—Memantine—Alzheimer's disease	0.00101	0.00113	CcSEcCtD
Atenolol—Asthenia—Rivastigmine—Alzheimer's disease	0.001	0.00112	CcSEcCtD
Atenolol—Rash—Donepezil—Alzheimer's disease	0.000991	0.00111	CcSEcCtD
Atenolol—Dermatitis—Donepezil—Alzheimer's disease	0.00099	0.00111	CcSEcCtD
Atenolol—Pruritus—Rivastigmine—Alzheimer's disease	0.000988	0.0011	CcSEcCtD
Atenolol—Headache—Donepezil—Alzheimer's disease	0.000985	0.0011	CcSEcCtD
Atenolol—Diarrhoea—Memantine—Alzheimer's disease	0.000976	0.00109	CcSEcCtD
Atenolol—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000955	0.00107	CcSEcCtD
Atenolol—Dizziness—Memantine—Alzheimer's disease	0.000944	0.00106	CcSEcCtD
Atenolol—Nausea—Donepezil—Alzheimer's disease	0.000934	0.00104	CcSEcCtD
Atenolol—Dizziness—Rivastigmine—Alzheimer's disease	0.000923	0.00103	CcSEcCtD
Atenolol—Ibuprofen—PTGS1—Alzheimer's disease	0.000922	0.0515	CrCbGaD
Atenolol—Rash—Memantine—Alzheimer's disease	0.0009	0.00101	CcSEcCtD
Atenolol—Dermatitis—Memantine—Alzheimer's disease	0.000899	0.00101	CcSEcCtD
Atenolol—Headache—Memantine—Alzheimer's disease	0.000894	0.001	CcSEcCtD
Atenolol—Rash—Rivastigmine—Alzheimer's disease	0.00088	0.000985	CcSEcCtD
Atenolol—Dermatitis—Rivastigmine—Alzheimer's disease	0.000879	0.000984	CcSEcCtD
Atenolol—Headache—Rivastigmine—Alzheimer's disease	0.000875	0.000978	CcSEcCtD
Atenolol—Nausea—Memantine—Alzheimer's disease	0.000848	0.000948	CcSEcCtD
Atenolol—Nausea—Rivastigmine—Alzheimer's disease	0.000829	0.000927	CcSEcCtD
Atenolol—Propranolol—CYP2D6—Alzheimer's disease	0.000553	0.0309	CrCbGaD
Atenolol—Ibuprofen—PTGS2—Alzheimer's disease	0.000527	0.0294	CrCbGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000162	0.00184	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000159	0.00181	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000159	0.0018	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—GAL—Alzheimer's disease	0.000158	0.0018	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000158	0.0018	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000155	0.00177	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—GAL—Alzheimer's disease	0.000155	0.00176	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—IL1B—Alzheimer's disease	0.000147	0.00167	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—CASP3—Alzheimer's disease	0.000147	0.00167	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.000145	0.00165	CbGpPWpGaD
Atenolol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	0.000144	0.00164	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—GAL—Alzheimer's disease	0.000144	0.00163	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—GAL—Alzheimer's disease	0.00014	0.0016	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TTR—Alzheimer's disease	0.00014	0.00159	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000139	0.00158	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TTR—Alzheimer's disease	0.000137	0.00156	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000136	0.00155	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.000135	0.00153	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—DHCR24—Alzheimer's disease	0.000126	0.00143	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	0.000125	0.00142	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—NPY—Alzheimer's disease	0.000124	0.00141	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000124	0.00141	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CCR5—Alzheimer's disease	0.000124	0.0014	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000123	0.0014	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PYY—Alzheimer's disease	0.000122	0.00139	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—NPY—Alzheimer's disease	0.000122	0.00138	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000121	0.00138	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000121	0.00137	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CCR5—Alzheimer's disease	0.000121	0.00137	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000121	0.00137	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CRH—Alzheimer's disease	0.00012	0.00136	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PYY—Alzheimer's disease	0.00012	0.00136	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000118	0.00134	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CRH—Alzheimer's disease	0.000117	0.00133	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	0.000114	0.0013	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—NPS—Alzheimer's disease	0.000114	0.00129	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—NPY—Alzheimer's disease	0.000113	0.00128	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IAPP—Alzheimer's disease	0.000112	0.00127	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—NPS—Alzheimer's disease	0.000111	0.00126	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—NPY—Alzheimer's disease	0.00011	0.00125	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IAPP—Alzheimer's disease	0.00011	0.00125	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CRH—Alzheimer's disease	0.000109	0.00124	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	0.000109	0.00124	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000108	0.00123	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—SST—Alzheimer's disease	0.000108	0.00123	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	0.000107	0.00121	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CA4—Alzheimer's disease	0.000107	0.00121	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CRH—Alzheimer's disease	0.000106	0.00121	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CDK5—Alzheimer's disease	0.000106	0.00121	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—F2—Alzheimer's disease	0.000106	0.00121	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000106	0.00121	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—SST—Alzheimer's disease	0.000106	0.00121	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—APP—Alzheimer's disease	0.000106	0.0012	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CDK5—Alzheimer's disease	0.000104	0.00118	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—F2—Alzheimer's disease	0.000104	0.00118	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—APP—Alzheimer's disease	0.000103	0.00117	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—NPS—Alzheimer's disease	0.000103	0.00117	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000103	0.00117	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HTR6—Alzheimer's disease	0.000102	0.00116	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—NPS—Alzheimer's disease	0.000101	0.00115	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.0001	0.00114	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	0.0001	0.00114	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HTR6—Alzheimer's disease	9.99e-05	0.00114	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PLCB1—Alzheimer's disease	9.97e-05	0.00113	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	9.92e-05	0.00113	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—SST—Alzheimer's disease	9.84e-05	0.00112	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—GAB2—Alzheimer's disease	9.84e-05	0.00112	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	9.79e-05	0.00111	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PLCB1—Alzheimer's disease	9.75e-05	0.00111	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—GAB2—Alzheimer's disease	9.63e-05	0.00109	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—SST—Alzheimer's disease	9.63e-05	0.00109	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—APP—Alzheimer's disease	9.59e-05	0.00109	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	9.52e-05	0.00108	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CCL2—Alzheimer's disease	9.45e-05	0.00107	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	9.42e-05	0.00107	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—APP—Alzheimer's disease	9.38e-05	0.00107	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PSENEN—Alzheimer's disease	9.28e-05	0.00105	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CCL2—Alzheimer's disease	9.25e-05	0.00105	CbGpPWpGaD
Atenolol—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	9.18e-05	0.00104	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—APH1A—Alzheimer's disease	9.15e-05	0.00104	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PLD3—Alzheimer's disease	9.08e-05	0.00103	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PSENEN—Alzheimer's disease	9.07e-05	0.00103	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PLCB1—Alzheimer's disease	9.05e-05	0.00103	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—APH1A—Alzheimer's disease	8.95e-05	0.00102	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NCSTN—Alzheimer's disease	8.91e-05	0.00101	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PLCB1—Alzheimer's disease	8.85e-05	0.00101	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NCSTN—Alzheimer's disease	8.71e-05	0.00099	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	8.71e-05	0.000989	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—LRP1—Alzheimer's disease	8.69e-05	0.000987	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—LRP1—Alzheimer's disease	8.5e-05	0.000966	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GFAP—Alzheimer's disease	8.48e-05	0.000964	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GAL—Alzheimer's disease	8.48e-05	0.000964	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	8.44e-05	0.000959	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	8.38e-05	0.000952	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GFAP—Alzheimer's disease	8.3e-05	0.000943	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GAL—Alzheimer's disease	8.3e-05	0.000943	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	8.22e-05	0.000934	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ND1—Alzheimer's disease	8.09e-05	0.00092	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	7.81e-05	0.000888	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—A2M—Alzheimer's disease	7.48e-05	0.00085	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PRKCG—Alzheimer's disease	7.37e-05	0.000838	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—A2M—Alzheimer's disease	7.31e-05	0.000831	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	7.25e-05	0.000824	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PSEN2—Alzheimer's disease	7.24e-05	0.000823	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PRKCG—Alzheimer's disease	7.21e-05	0.00082	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PSEN2—Alzheimer's disease	7.08e-05	0.000805	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CCR5—Alzheimer's disease	6.98e-05	0.000794	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—HTR2A—Alzheimer's disease	6.84e-05	0.000777	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CCR5—Alzheimer's disease	6.83e-05	0.000777	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PRKCG—Alzheimer's disease	6.69e-05	0.000761	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—HTR2A—Alzheimer's disease	6.69e-05	0.00076	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NPY—Alzheimer's disease	6.66e-05	0.000757	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	6.66e-05	0.000757	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IAPP—Alzheimer's disease	6.62e-05	0.000753	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PRKCG—Alzheimer's disease	6.55e-05	0.000744	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NPY—Alzheimer's disease	6.52e-05	0.000741	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IAPP—Alzheimer's disease	6.48e-05	0.000736	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CRH—Alzheimer's disease	6.43e-05	0.000731	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CCR5—Alzheimer's disease	6.34e-05	0.000721	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CRH—Alzheimer's disease	6.29e-05	0.000715	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—HTR2A—Alzheimer's disease	6.21e-05	0.000705	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CCR5—Alzheimer's disease	6.2e-05	0.000705	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	6.15e-05	0.000699	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NPS—Alzheimer's disease	6.1e-05	0.000693	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—HTR2A—Alzheimer's disease	6.07e-05	0.00069	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PPP3CA—Alzheimer's disease	6.06e-05	0.000689	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—F2—Alzheimer's disease	5.99e-05	0.000681	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PTK2B—Alzheimer's disease	5.98e-05	0.000679	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NPS—Alzheimer's disease	5.96e-05	0.000678	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PPP3CA—Alzheimer's disease	5.93e-05	0.000674	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.9e-05	0.000671	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—F2—Alzheimer's disease	5.86e-05	0.000666	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PTK2B—Alzheimer's disease	5.85e-05	0.000665	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GAB2—Alzheimer's disease	5.81e-05	0.000661	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SST—Alzheimer's disease	5.81e-05	0.000661	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NTRK2—Alzheimer's disease	5.81e-05	0.000661	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CALM1—Alzheimer's disease	5.79e-05	0.000658	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GSK3A—Alzheimer's disease	5.76e-05	0.000655	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SST—Alzheimer's disease	5.69e-05	0.000646	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GAB2—Alzheimer's disease	5.69e-05	0.000646	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NTRK2—Alzheimer's disease	5.69e-05	0.000646	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—APP—Alzheimer's disease	5.67e-05	0.000644	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CALM1—Alzheimer's disease	5.66e-05	0.000644	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	5.65e-05	0.000642	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	5.64e-05	0.000641	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—APP—Alzheimer's disease	5.54e-05	0.00063	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	5.44e-05	0.000619	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	5.35e-05	0.000608	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	5.32e-05	0.000605	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	5.27e-05	0.000599	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	5.23e-05	0.000594	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—TPI1—Alzheimer's disease	5.22e-05	0.000593	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CHAT—Alzheimer's disease	5.22e-05	0.000593	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—MAOB—Alzheimer's disease	5e-05	0.000568	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	4.99e-05	0.000567	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	4.96e-05	0.000563	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	4.88e-05	0.000555	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	4.87e-05	0.000554	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	4.85e-05	0.000551	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	4.85e-05	0.000551	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GAPDH—Alzheimer's disease	4.81e-05	0.000547	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	4.77e-05	0.000542	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	4.74e-05	0.000539	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—A2M—Alzheimer's disease	4.65e-05	0.000528	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	4.65e-05	0.000528	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	4.61e-05	0.000524	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	4.51e-05	0.000512	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	4.39e-05	0.000499	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	4.29e-05	0.000488	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	4.24e-05	0.000482	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	4.15e-05	0.000472	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	4.07e-05	0.000462	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ACHE—Alzheimer's disease	4.04e-05	0.00046	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	4.03e-05	0.000458	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—INPP5D—Alzheimer's disease	4e-05	0.000454	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	3.98e-05	0.000452	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	3.95e-05	0.000449	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	3.94e-05	0.000448	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	3.92e-05	0.000446	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	3.87e-05	0.00044	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	3.85e-05	0.000438	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PTGS1—Alzheimer's disease	3.79e-05	0.000431	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ENO1—Alzheimer's disease	3.79e-05	0.000431	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	3.77e-05	0.000428	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	3.75e-05	0.000426	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	3.72e-05	0.000422	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	3.67e-05	0.000417	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	3.67e-05	0.000417	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	3.59e-05	0.000408	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—BCHE—Alzheimer's disease	3.52e-05	0.0004	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	3.42e-05	0.000389	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	3.41e-05	0.000387	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	3.41e-05	0.000387	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	3.38e-05	0.000384	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	3.35e-05	0.00038	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	3.33e-05	0.000379	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	3.33e-05	0.000379	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PLCB1—Alzheimer's disease	3.32e-05	0.000378	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	3.3e-05	0.000376	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	3.25e-05	0.00037	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ABCA1—Alzheimer's disease	3.22e-05	0.000366	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—F2—Alzheimer's disease	3.21e-05	0.000365	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	3.18e-05	0.000362	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	3.15e-05	0.000358	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—F2—Alzheimer's disease	3.14e-05	0.000357	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	3.08e-05	0.00035	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	2.95e-05	0.000336	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	2.93e-05	0.000333	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—INS—Alzheimer's disease	2.91e-05	0.000331	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	2.89e-05	0.000328	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	2.87e-05	0.000326	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	2.86e-05	0.000326	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—INS—Alzheimer's disease	2.85e-05	0.000324	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	2.82e-05	0.00032	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	2.8e-05	0.000319	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	2.78e-05	0.000316	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HMOX1—Alzheimer's disease	2.76e-05	0.000314	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	2.76e-05	0.000313	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	2.55e-05	0.00029	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—LPL—Alzheimer's disease	2.53e-05	0.000287	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	2.5e-05	0.000284	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—MTHFR—Alzheimer's disease	2.28e-05	0.000259	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.19e-05	0.000249	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	2.17e-05	0.000246	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	2.15e-05	0.000245	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	2.14e-05	0.000243	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CALM1—Alzheimer's disease	2.13e-05	0.000242	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	2.12e-05	0.000241	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—APOE—Alzheimer's disease	2.12e-05	0.000241	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	2.11e-05	0.000239	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CAV1—Alzheimer's disease	2.1e-05	0.000239	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	1.99e-05	0.000226	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	1.99e-05	0.000226	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	1.95e-05	0.000222	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	1.94e-05	0.000221	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.85e-05	0.00021	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	1.84e-05	0.000209	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—INS—Alzheimer's disease	1.81e-05	0.000206	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	1.8e-05	0.000205	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	1.69e-05	0.000192	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	1.65e-05	0.000188	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.59e-05	0.00018	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.45e-05	0.000165	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	1.39e-05	0.000158	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	1.36e-05	0.000155	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	1.27e-05	0.000145	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	1.24e-05	0.000141	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	1.17e-05	0.000133	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	1.15e-05	0.000131	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—AKT1—Alzheimer's disease	7.3e-06	8.3e-05	CbGpPWpGaD
